Other languages Johnson & Johnson Buenos Aires S.E.

Equities

JNJD

ARDEUT110236

End-of-day quote Buenos Aires S.E. Other stock markets 03:30:00 03/06/2024 am IST			5-day change	1st Jan Change
10.45 ^USD	+2.45%		+3.47%	+2.45%

03/06	Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	MT
03/06	J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO	RE

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	04/06
Johnson & Johnson Completes Acquisition of Shockwave Medical	03/06
Johnson & Johnson - First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related reactions with five-minute subcutaneous amivantamab administration	03/06
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO	03/06
J&J-backed Rapport Therapeutics seeks to raise $144 mln in US IPO	03/06
GSK blood cancer drug nearly halves risk of death in late-stage trial	02/06
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01/06
Johnson & Johnson Announces First Data from the Phase 3 PALOMA-3 Study Evaluating Subcutaneous (SC) Amivantamab Combined with Lazertinib	01/06
Sector Update: Health Care Stocks Higher Late Afternoon	01/06
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01/06
Sector Update: Health Care Stocks Advance Friday Afternoon	31/05
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	31/05
Johnson & Johnson Executive Vice President, William N. Hait, M.D., Ph.D., to Retire, Effective September 2024	31/05
J&J : finalise l'acquisition de Shockwave Medical	31/05
Johnson & Johnson Closes Acquisition of Shockwave Medical	31/05
Johnson & Johnson Completes Acquisition of Shockwave Medical	31/05
Johnson & Johnson Completes Acquisition of Shockwave Medical	31/05
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	31/05
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30/05
Johnson & Johnson : to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) Press Release	30/05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST